Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Sima Lotfi
ID:
1b838da9-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
3 articles
Updates on Patent Challenges by Biosimilar Manufacturers at the PTAB
Big Molecule Watch ·
December 21, 2023
cite
Recent Biosimilar Commercialization Developments
Big Molecule Watch ·
September 28, 2023
cite
FDA Approves Regeneron’s 8 mg injection of EYLEA (aflibercept) and VEOPOZ (pozelimab)
Big Molecule Watch ·
August 28, 2023
cite